"The Mass General Cancer Center at Emerson Hospital – Bethke offers comprehensive cancer care in Concord, Massachusetts"

During the past decade, Bethke Cancer Center at Emerson Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bethke Cancer Center at Emerson Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 2 trials, followed by "ETOP IBCSG Partners Foundation" with 2 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored, "Dana-Farber Cancer Institute" with 1 trials sponsored and "Massachusetts General Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bethke Cancer Center at Emerson Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Bethke Cancer Center at Emerson Hospital" are "Breast Cancer" (5 trials), "Anal Cancer" (1 trials), "Chemotherapeutic Agent Toxicity" (1 trials), "Estrogen Receptor Positive Breast Cancer" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Bethke Cancer Center at Emerson Hospital" in a lesser frequency.

Most popular intervention types in "Bethke Cancer Center at Emerson Hospital" are "Drug" (7 trials), "Radiation" (4 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (2 trials), "Amifostine" (1 trials), "Carboplatin" (1 trials), "Culturally Aware Adjuvant Endocrine Therapy (AET) Non-Initiation Intervention" (1 trials) and "Exemestane" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bethke Cancer Center at Emerson Hospital" are 6 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Bethke Cancer Center at Emerson Hospital". 1 are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Bethke Cancer Center at Emerson Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bethke Cancer Center at Emerson Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".